JDNPPA Expert Reaction: U.S. FDA Approves Ruxolitinib Cream for Young Kids With AD
Kara Mudd, DMSc, PA-C, weighs in on the recent FDA approval of ruxolitinib cream for the treatment AD in children as young as 2.
Category: News and Views
Kara Mudd, DMSc, PA-C, weighs in on the recent FDA approval of ruxolitinib cream for the treatment AD in children as young as 2.